Research Articles

People with diabetes have long been at the forefront of adopting digital health technologies, using digital platforms to seek out support, information about their condition, and to better understand the data that comes from managing it. The growing integration of wearable sensors and device data into digital health apps provides people with diabetes support right at their fingertips.

Diabetes is a chronic condition that affects millions of people worldwide. The condition requires close and careful management to avoid severe health consequences. Today, people with diabetes have access to sophisticated automated insulin dosing (AID) systems that help in many aspects of diabetes management. IDTechEx forecasts that with further developments in AID systems, the diabetes management market can reach US$44 billion by 2035.

The rise of Continuous Glucose Monitoring (CGM) has reshaped the diabetes management technology market. With the market projected to reach US$44 billion by 2035, CGM technology is transforming diabetes care by replacing painful fingerstick tests and providing real-time glucose insights.

With over 800 million people with diabetes in the world today, the market for diabetes management is substantial. IDTechEx forecasts the market for diabetes management technologies to exceed US$44 billion by 2035, with continuous glucose monitors (CGM) and insulin pump markets driving growth in the next ten years.

With every successive year, the lines between medical devices and consumer electronics become increasingly blurred - medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications as a key focus for their wearable products.

Healthcare systems around the world are being put under increasing strain every year. Key challenges they face include overburdened medical staff and a steady rise in patients with chronic health conditions that require high levels of care.

By now, antimicrobial technologies are well known to the general public, being applied to products ranging from antimicrobial coatings to protect people from bacteria and viruses lingering on high-touch surfaces to antimicrobial infused shirts and socks to help limit malodor.

Healthcare-associated infections (HAI), also known as hospital-acquired infections, are a major problem healthcare systems face worldwide. Each year, millions of patients contract infectious diseases while in hospital.

The cultured meat industry passed a key milestone in June 2023 - two companies, GOOD Meat and UPSIDE Foods, received approval to begin the commercialization of their cultivated chicken products in the USA.

Wednesday 5 July 2023 - Learnings From the COVID-19 Pandemic. What are the key antimicrobial technologies on the market today? What are the key applications for antimicrobial technologies, and what are the drivers? How do antimicrobial technologies work? How do they provide residual protection against microorganisms? What product and market trends were observed during the COVID-19 pandemic? What can we expect in the next global pandemic?

IDTechEx have recently published the market research report "Antiviral and Antimicrobial Technology Market 2023-2033", covering additives and coatings that can provide residual antimicrobial protection to surfaces.

Dr Nadia Tsao and Andy Ko discuss the latest developments in Cultured Meat. Visit www.IDTechEx.com/CulturedMeat for more information.

Rising healthcare costs, an aging population and an increasing prevalence of chronic diseases are driving the uptake of remote patient monitoring (RPM) technologies. In their recent report, Remote Patient Monitoring 2023 - 2033: Technologies, Markets and Opportunities, IDTechEx forecasts the market for medical devices supporting RPM to reach US$45 billion by 2033.

IDTechEx Reflects on Trends in 2022. For the past decade, the healthcare industry has looked towards decentralization as a means of relieving the pressure placed on healthcare systems.

Remote patient monitoring (RPM), referring to the use of technology to measure and transmit physiologic data beyond traditional healthcare settings, has emerged as a promising solution to drive down healthcare costs while maintaining a high standard of care for patients.

The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients.

AI in drug discovery is a field that has received an immense increase in interest, uptake, and investment over the past year due to the COVID-19 pandemic. While lockdowns forced everyone around the world to explore virtual ways of working, the biopharma industry faced the additional task of quickly developing new drugs for the treatment of COVID-19. Enter the application of AI in drug discovery - a technology that promises to drastically cut down timelines and costs, and potentially, develop safer and more efficacious drugs.

AI has been successfully applied to speed up virtual screening, de novo drug discovery, and can be utilized to optimize compounds to have drug-like properties. Processes that typically take several years can be reduced to a matter of months.

Antimicrobial technologies such as coatings and textiles containing silver and copper are helping people during the COVID-19 pandemic by ensuring that whatever they touch, whether that is a door handle or their own mask, is free from live SARS-CoV-2 particles. But how exactly do these antimicrobial technologies work?

Today, antimicrobial technologies are used around the world in response to the COVID-19 pandemic. Surfaces and products protected by antimicrobial technology can continuously inactivate and kill harmful microorganisms such as the SARS-CoV-2 virus. In this article, IDTechEx highlights three innovative start-ups that are developing next-generation antimicrobial technologies.

COVID-19 is driving 3- and 4-digit growth for antimicrobial companies - this market has received significant attention from governments, industry, and even consumers over the past year (2020) due to the technology's potential to address transmission of COVID-19.

At IDTechEx, we cover emerging technologies and industry trends, and the COVID-19 pandemic has had a direct or indirect impact on all of them. In this article we will describe some of the key roles that these technologies have played in 2020.

IDTechEx finds significant progress for companies developing non-invasive peripheral nerve stimulation technologies

IDTechEx forecasts that flexible electronics in cardiac monitoring, deployed in electronic skin patches and electronic textiles, will be a $2 billion market in the year 2030.

IDTechEx have released a new research report, "Skin Sensors 2020- 2030: Technologies, Markets, Players, Forecasts".

With a surface area of up to 2 square meters, skin is the largest organ of the human body. Skin acts as an outer covering and barrier - not only is skin health crucial to the overall health of an individual, but skin appearance has significant societal impact as well (body image, communication, etc.).

3D bioprinting provides scientists with the unique ability to create artificial tissue that closely resembles native tissue in form and function. A method of tissue engineering, 3D bioprinting is the precise deposition of cells, typically layer-by-layer, to realize a final 3D construct. Over the years, 3D bioprinting has seen increased adoption as a research tool and as a method for tissue engineering in regenerative medicine.

While traditional electronic systems have an inherently rigid form factor, developments in manufacturing processes and materials are enabling a new world of flexible electronics. IDTechEx forecasts the market for healthcare products containing flexible electronics to be worth over $8.3 billion by the year 2030.

Telehealth has been poised to disrupt healthcare for many years, but unfortunately has faced a slow rise in adoption. This has changed in the COVID-19 crisis.

Artificial intelligence is revolutionizing medical diagnostics. This is a ground-breaking development with far-reaching consequences. Naturally, many innovators are scrambling to capitalize on these advancements.

Attendees of Healthcare Sensor Innovations USA 2020 will hear from industry representatives on how advanced sensors, sensor fusion, algorithms, analytics and artificial intelligence can enable point-of-care testing and the movement towards the decentralization of healthcare.

IDTechEx identifies top future technologies in healthcare. With demographic changes such as the aging of the population, they forecast there to be strong growth in technologies that help healthcare providers manage the growing burden on the healthcare system while maintaining high quality care.

Healthcare Sensor Innovations 2020, hosted in San Jose on March 17-18, identifies and assesses the opportunities for printed and flexible electronics in healthcare as the technology enables a new wave of medical wearable devices.

Healthcare Sensor Innovations North America debut on Marc, 17-18, 2020 in San Jose, USA will focus on the latest developments in the use of wearables and sensors in point of care diagnostics and continuous monitoring.

Attendees at Healthcare Sensor Innovations USA 2020 will hear from industry representatives on how the next wave of connected and wearable medical devices will bring increased benefits to patients, healthcare providers, insurers, and the pharmaceutical industry.

Held over 20 - 21 November 2019 at the Santa Clara Convention Center in Santa Clara, USA, the latest edition of the IDTechEx Show! will once again feature the application of emerging technologies to the healthcare industry.